Filing Details

Accession Number:
0001567619-21-017578
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-09-24 17:35:59
Reporting Period:
2021-09-22
Accepted Time:
2021-09-24 17:35:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1604464 Atara Biotherapeutics Inc. ATRA Biological Products, (No Disgnostic Substances) (2836) 460920988
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1702457 Joe Newell C/O Atara Biotherapeutics, Inc.
611 Gateway Blvd., Suite 900
South San Francisco CA 94080
Chief Operations Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-09-22 10,500 $12.15 130,429 No 4 M Direct
Common Stock Disposition 2021-09-22 10,500 $17.00 119,929 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Disposition 2021-09-22 8,375 $17.00 8,375 $12.15
Common Stock Employee Stock Option (Right to Buy) Disposition 2021-09-22 2,125 $17.00 2,125 $12.15
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
34,875 2030-02-28 No 4 M Direct
10,625 2030-02-28 No 4 M Direct
Footnotes
  1. Transaction pursuant to Rule 10b5-1 Plan adopted September 14, 2020.
  2. 1/48th of the shares subject to the stock option vest and become exercisable each month with the initial installment vesting on April 1, 2020, subject to the reporting person's continuous service.